Patents by Inventor Bruno Peault

Bruno Peault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Perivascular stem cell composition for bone
    Patent number: 9730965
    Abstract: Embodiments of the present invention provide an osteogenic composition comprising perivascular stem cells or induced pluripotent cells (iPS) and an osteogenic agent and methods of making and using the same.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: August 15, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: B. Chia Soo, Kang Ting, Bruno Peault
  • Perivascular Stem Cell Composition For Bone
    Publication number: 20120244128
    Abstract: Embodiments of the present invention provide an osteogenic composition comprising perivascular stem cells or induced pluripotent cells (iPS) and an osteogenic agent and methods of making and using the same.
    Type: Application
    Filed: February 10, 2012
    Publication date: September 27, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: B. Chia Soo, Kang Ting, Bruno Peault
  • Cardiac Compositions
    Publication number: 20120237560
    Abstract: Embodiments of the present invention provide a composition comprising perivascular stem cells or induced pluripotent cells (iPS) and a NELL-1 factor for cardiac or vascular regeneration and methods of making and using the same.
    Type: Application
    Filed: February 10, 2012
    Publication date: September 20, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: B. Chia Soo, Kang Ting, Bruno Peault
  • ISOLATION OF PERICYTES
    Publication number: 20070264239
    Abstract: In one embodiment, the invention provides a pericyte having a marker pattern comprising CD146+, CD34?, and CD45?, wherein said pericyte is substantially isolated from cells that are CD146? or CD31+ or CD34+ or CD45+ or CD56+ or NG2? or CD133?. The invention also provides populations of such pericytes. In another embodiment, the invention provides a method for isolating a pericyte. In another embodiment, the invention provides a method for modeling tissue in vivo.
    Type: Application
    Filed: May 10, 2007
    Publication date: November 15, 2007
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: Johnny Huard, Bruno Peault
  • T-lymphocyte progenitor cell assay
    Patent number: 5147784
    Abstract: Methodology is provided for identifying the presence of human T-lymphocyte progenitor cells. Human thymus tissue is depleted of endogenous lymphold cells, repopulated with a human cellular composition which is HLA mismatched with the thymus tissue and implanted into a vascularizable site in an immunocompromised host. After at least about 2 weeks, the tissue may be assayed for the presence of the HLA mismatched T-lymphocytes as indicative of human T-lymphocyte progenitors in this cellular composition.
    Type: Grant
    Filed: April 12, 1990
    Date of Patent: September 15, 1992
    Assignee: SyStemix, Inc.
    Inventor: Bruno Peault